Delivery Order SPE2DE24D0013-SPE2D625F3NVY

The U.S. Defense Department's Medical Supply Chain awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a molecular diagnostics manufacturer based in Sunnyvale, California. This award, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents a standard delivery order contract type. The contract enables procurement of Cepheid's diagnostic solutions, which the company supplies across multiple federal healthcare systems including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency.

Cepheid specializes in advanced molecular diagnostic systems and test kits designed to detect infectious diseases and clinical conditions, with core products including GeneXpert diagnostic systems and associated reagents. The company maintains substantial federal presence through two significant Indefinite Delivery Vehicle contracts with the VA's Veterans Integrated Service Networks, valued at approximately $32.8 million and $2.5 million respectively, which support ongoing procurement of PCR testing systems and molecular diagnostic reagents for conditions including COVID-19, influenza, RSV, and tuberculosis. This delivery order aligns with Cepheid's established role as a key federal supplier of diagnostic testing capabilities supporting defense and veterans healthcare infrastructure.